TP53 and colorectal carcinoma: Together, the survival analysis and experimental correlations prompted us to hypothesize that PD-L1 expression induced by IFN-γ is a key mechanism underlying anti-PD-1/PD-L1-mediated immune responses in wild-type KRAS and wild-type TP53 CRC.